Skip to main content
. 2021 Feb 8;81(2):152–182. doi: 10.1055/a-1259-1609

Table 7  Relevance of different VTE risk factors and recommendations for prescribing contraceptives; adapted from the UKMEC.

Risk factor for VTE Relevance for VTE risk when taking hormonal contraceptives Recommended actions
#   According to the 2015 World Health Organization (WHO) guideline, patients with no thrombophilia but with a positive familial history of thrombophilia may take COC.
Age > 35 years low – moderate Provide extensive advice about risks; in principle, all forms of contraception are possible
BMI > 35 kg/m 2 low – moderate Provide extensive advice about risks; taking COC should be avoided if possible
Smoking (cigarettes) low – moderate Provide extensive advice about risks; taking COC should be avoided if possible (particularly if older than 35 years and/or smoking > 15 cig./day)
≥ 2 of the risk factors listed below
  • age > 35 years

  • BMI > 35 kg/m 2

  • Smoking

moderate – high Provide extensive advice about risks; taking COC should be avoided if possible
Prolonged immobility, major surgical procedure moderate – high Provide extensive advice about risks; patient should not be started on COC; consistent thrombosis prophylaxis prescribed for COC users
Patient has previous history of VTE moderate (triggered VTE)
to high (unprovoked or hormone-related VTE)
Taking COC should be avoided; consider consulting a hemostaseology specialist (if consulted, the specialist should test for thrombophilia)
Familial history positive for VTE, with VTE occurring in first-degree relatives below the age of 45 moderate (triggered VTE)
to high (idiopathic or hormone-related VTE)
Taking COC # should be avoided; consider consulting a hemostaseology specialist (if consulted, the specialist should test for thrombophilia)
Familial history positive for VTE, with VTE occurring in first-degree relatives above the age of 45 low – moderate Provide extensive advice about risks; taking COC is possible # if no suitable alternatives are available
Asymptomatic thrombophilia
or thrombophilia reported in first-degree relatives
low – high
depending on the type of thrombophilia and its manifestation in the family
Testing for thrombophilia is indicated and critically important for asymptomatic patients; if thrombophilia is proven, consult with a hemostaseology specialist before starting hormonal contraception